Industry considers green-chemistry standards
An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway.
An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway. Robert Peoples, director of the American Chemical Society’s (ACS) Green Chemistry Institute, provided an update of the initiative at the ACS National Meeting in Washington DC, according to an online article of Chemical and Engineering News (C&EN), an ACS publication. The ACS is an organization representing chemists and professionals involved in the field of chemistry.
C&EN reported that nearly 50 stakeholders are helping to establish the green standard, which is expected to be completed in draft form for public comment by the end of this year. The aim is to have the standard certified by the American National Standards Institute (ANSI) in June 2010, according to the C&EN article. ANSI is a nonprofit association that functions as an administrator and coordinator of the US private-sector voluntary standardization system.
The standard will set criteria for chemical producers and users to evaluate the environmental impact and sustainability attributes of chemicals and their derivatives, according to the article. The ACS, chemical and pharmaceutical companies, the American Chemistry Council (which is the US-based trade association representing chemical manufacturers), nonprofit environmental organizations, and academia are participating in the process to develop the standard, according to C&EN.
The ACS Green Chemistry Institute focuses on promoting the understanding of green chemistry and green engineering. In 2005, the ACS Green Chemistry Institute and several major pharmaceutical companies developed the ACS GCI Pharmaceutical Roundtable to encourage the innovation and integration of green chemistry and green engineering in the pharmaceutical industry.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
